• Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

Seed
Total Funding-

Recent News about GlucoMe

Edit
More about GlucoMeinfo icon
Edit

GlucoMe is a digital diabetes care platform designed to streamline and simplify diabetes management for patients, caregivers, medical professionals, and payers. The company operates in the healthcare technology market, providing a comprehensive solution that includes a wireless blood glucose monitor and a user-friendly mobile app compatible with both iOS and Android devices. The platform enables real-time monitoring and communication of blood glucose data, enhancing the accuracy and efficiency of diabetes care.

GlucoMe's primary clients include individual patients managing diabetes, healthcare providers seeking better control and visibility over patient care, and insurers looking to optimize diabetes treatment plans. The business model revolves around the sale of its blood glucose monitoring devices and the subscription-based services offered through its mobile application. Revenue is generated from device sales, app subscriptions, and potentially from partnerships with healthcare providers and insurers.

The company's innovative approach not only simplifies diabetes monitoring but also reduces the overall burden of diabetes management. By integrating advanced technology with practical usability, GlucoMe aims to improve the quality of life for those affected by diabetes while providing valuable data and insights to healthcare professionals.

Keywords: digital diabetes care, blood glucose monitor, mobile app, healthcare technology, real-time monitoring, patient management, caregiver support, medical professionals, insurers, diabetes management.